Deutsche Bank
HRMY icon

Deutsche Bank’s Harmony Biosciences HRMY Stock Holding History

Deutsche Bank’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.7M Sell
101,612
-83,333
-45% -$2.63M ﹤0.01% 1534
2026
Q1 		$5.18M Sell
184,945
-159,226
-46% -$5.22M ﹤0.01% 1281
2025
Q4 		$12.9M Sell
344,171
-81,530
-19% -$2.68M ﹤0.01% 1005
2025
Q3 		$11.7M Buy
425,701
+200,532
+89% +$6.91M ﹤0.01% 1007
2025
Q2 		$7.12M Buy
225,169
+148,392
+193% +$4.77M ﹤0.01% 1100
2025
Q1 		$2.55M Sell
76,777
-9,172
-11% -$329K ﹤0.01% 1590
2024
Q4 		$2.96M Buy
85,949
+18,939
+28% +$651K ﹤0.01% 1608
2024
Q3 		$2.68M Buy
67,010
+21,728
+48% +$763K ﹤0.01% 1585
2024
Q2 		$1.37M Sell
45,282
-4,353
-9% -$131K ﹤0.01% 1840
2024
Q1 		$1.67M Sell
49,635
-32,252
-39% -$1.04M ﹤0.01% 1757
2023
Q4 		$2.64M Buy
81,887
+65,420
+397% +$1.83M ﹤0.01% 1528
2023
Q3 		$540K Sell
16,467
-58,008
-78% -$2.01M ﹤0.01% 2116
2023
Q2 		$2.62M Buy
74,475
+26,313
+55% +$908K ﹤0.01% 1498
2023
Q1 		$1.57M Sell
48,162
-75,266
-61% -$3.43M ﹤0.01% 1823
2022
Q4 		$6.8M Buy
123,428
+79,862
+183% +$4.39M ﹤0.01% 1109
2022
Q3 		$1.93M Buy
43,566
+30,352
+230% +$1.48M ﹤0.01% 1643
2022
Q2 		$645K Sell
13,214
-54
-0.4% -$2.43K ﹤0.01% 2438
2022
Q1 		$645K Sell
13,268
-1,243
-9% -$50.7K ﹤0.01% 2599
2021
Q4 		$618K Sell
14,511
-76,865
-84% -$3.06M ﹤0.01% 2706
2021
Q3 		$3.5M Buy
91,376
+8,255
+10% +$266K ﹤0.01% 1715
2021
Q2 		$2.35M Buy
83,121
+79,142
+1,989% +$2.37M ﹤0.01% 2082
2021
Q1 		$131K Sell
3,979
-378
-9% -$13.3K ﹤0.01% 3833
2020
Q4 		$158K Buy
+4,357
New +$176K ﹤0.01% 3597

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank's HRMY Position: Q2 2026 in Review

Deutsche Bank reduced its Harmony Biosciences (HRMY) stake by 45% in Q2 2026, selling an estimated $2.63M and leaving 101,612 shares worth $3.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1534.

Deutsche Bank first reported a position in HRMY in Q4 2020 and has held it in 23 quarters since. The position peaked at $12.9M in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Deutsche Bank held 101,612 shares of Harmony Biosciences worth $3.7M as of Q2 2026.
  • Deutsche Bank sold 83,333 Harmony Biosciences shares in Q2 2026, an estimated $2.63M.
  • Harmony Biosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1534 holding.
  • Deutsche Bank first reported a position in Harmony Biosciences in Q4 2020 and has held it in 23 quarters since.
  • Deutsche Bank's Harmony Biosciences position peaked at $12.9M in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.